Drug delivery

World Malaria Day: Five latest devices to combat the spread of malaria

For World Malaria Day, we profile five medical devices preventing the spread of malaria across the developing regions of the world

Fe3 Medical concludes first human study of iontophoretic transdermal technology

Fe3 Medical, a manufacturer of transdermal patch for treating iron deficiency anemia, has announced the results from its first human study of the Fe3 biphasic iontophoretic transdermal technology.

Epilepsy medicine supply at risk as UK becomes a ‘less desirable market’

The government is being urged to review the supply of epilepsy medicine, a problem that has been ongoing "for over a decade," and worsened by Brexit

Profiling six African entrepreneurs attending the Go Global Africa programme

Twenty African entrepeneurs will act as Go Global champions after receiving coaching from pitching experts and public speaking masterclasses

Aptar Pharma secures approval in US for Bidose nasal drug delivery device

The US Food and Drug Administration (FDA) has approved Aptar Pharma's Bidose nasal spray device for a breakthrough therapy in the field of depression.

Solasia files new medical device application for episil in South Korea

SolasiaPharma has filed a New Medical Device Application for episil oral liquid (SP-03, hereinafter ‘episil’) to the Regulatory Authority in South Korea.

MIT researchers devise new way to reduce burden of tuberculosis treatment

A research team from the Massachusetts Institute of Technology (MIT) in the US has devised a new way to deliver antibiotics against tuberculosis (TB) , which is one of the world’s deadliest infectious diseases.

World Sleep Day: The Dreem smart headband developing healthy sleeping habits

With its brain-activity monitoring tools, sleep science company Dreem is solving sleep-related problems of chronic insomnia affecting 10% of the worlds population, which World Sleep Day is addressing today

VIVA Physicians selects NAMSA to assess safety of paclitaxel drug-eluting technologies in PAD

VIVA Physicians has selected NAMSA as the independent statistical analysis group to examine individual patient-level data (IPD) associated with paclitaxel-coated balloons and stent trials used in the treatment of peripheral artery disease (PAD) in the superficial femoral artery.